Comparison of 12-Month Outcomes with Zotarolimus- and Paclitaxel-Eluting Stents: A Meta-Analysis

Table 1

Summary of heterogeneity analysis.

	Q	dF	P-value	Result
MI	1.6724	3	.6431	Homogenous
MACE	3.1045	2	.2118	Homogenous
Cardiac death	0.8357	3	.8357	Homogenous
All-cause death	3.1045	2	.2118	Homogenous
Stent thrombosis	0.2858	3	.9627	Homogenous
Target vessel revascularization	6.7677	3	.0797	Homogenous
Target lesion revascularization	5.8443	2	.0538	Homogenous

dF: degrees of freedom.